Incruse Ellipta

Indicated For

COPD

About This Medication

# GSK Patient Assistance Program Patient Guide: How to Get Incruse Ellipta at Low or No Cost Incruse Ellipta (umeclidinium) is a once-daily inhaled **long-acting muscarinic antagonist (LAMA)** used to help control symptoms of **chronic obstructive pulmonary disease (COPD)** in adults, such as shortness of breath and chronic cough. The **GSK Patient Assistance Program** offers this medication **at no cost** to eligible patients who meet specific financial and insurance criteria, making it accessible for those struggling with out-of-pocket costs. ## About Incruse Ellipta **Incruse Ellipta** is a prescription inhaler containing umeclidinium, a bronchodilator that relaxes muscles around the airways in the lungs, improving airflow and reducing COPD flare-ups. It's not a rescue inhaler for sudden symptoms but a maintenance therapy taken once daily. Common side effects include headache, cough, and upper respiratory infections; always consult your doctor for personalized advice. This program helps ensure you can stick to your treatment plan without financial barriers.[1][2] ## Who Qualifies for the Program? The GSK Patient Assistance Program, managed by the independent GSK Patient Access Programs Foundation, provides free GSK medications like Incruse Ellipta to qualifying U.S. patients (including Puerto Rico and sometimes U.S. Virgin Islands for certain products). Key requirements include: - **Residency**: Live in the United States or Puerto Rico. - **Financial Need**: Household income at or below **400% of the Federal Poverty Level (FPL)**. - **Insurance Status**: Uninsured or lacking prescription coverage; **Medicare Part D patients are generally not eligible** unless they meet special criteria like spending $600+ on prescriptions in the calendar year (separate process).[1][4][6] - **Prescription**: Valid prescription from a U.S.-licensed healthcare provider. - **Treatment**: Must be prescribed for an FDA-approved use. **Note**: This is a charitable program, not insurance. Availability depends on the product and your situation.[2] ## Income Eligibility Breakdown Eligibility is based on **total household income** compared to **400% FPL**. Use the table below for 2026 guidelines (FPL updates annually; check HHS.gov for exact figures). For a household of 1, 400% FPL is approximately $60,240; add ~$20,000 per additional member. | Household Size | 100% FPL (approx.) | 400% FPL Threshold (approx.) | |----------------|---------------------|------------------------------| | 1 (Individual) | $15,060 | $60,240 | | 2 (Couple) | $20,440 | $81,760 | | 3 | $25,820 | $103,280 | | 4 | $31,200 | $124,800 | | +1 Member | +$5,380 | +$21,520 | **How to Calculate**: Include all taxable income (wages, Social Security, etc.) before taxes. Proof required (e.g., tax returns, pay stubs). Pre-screen eligibility online at gskforyou.com or call 1-866-728-4368.[2][6][10] ## Insurance Requirements - **Eligible**: Completely uninsured for prescriptions or have no coverage that pays for Incruse Ellipta. - **Ineligible**: Patients with **Medicare Part D** (standard cases); private insurance covering the drug; government plans like Medicaid (unless denied). The program verifies your status and may contact your insurer. If you have coverage, explore GSK's copay assistance instead.[1][4][6] ## Step-by-Step Application Process 1. **Check Eligibility**: Visit gskforyou.com/programs/patient-assistance-program/ and answer quick questions, or call **1-866-728-4368** (Mon-Fri, 8am-8pm ET).[2][10] 2. **Get Your Prescription**: Ask your doctor for a signed original prescription for Incruse Ellipta (faxed OK if from doctor's office with cover sheet).[1][3] 3. **Gather Documents**: - Proof of income (e.g., 2025 tax return, W-2s, pay stubs covering 3 months). - Proof of residency (e.g., utility bill, lease). - Signed application (download from gskforyou.com).[1][3] 4. **Complete Application**: Fill out all sections (patient info, consent, prescriber details). Sign and date. Advocates can assist (register at GSKPatientAssistancePortal.com).[1][3] 5. **Submit**: Fax to 1-855-474-3063 or mail to PO Box 220590, Charlotte, NC 28222-0590. Keep copies![1] **Tip**: Incomplete apps delay processing—double-check everything.[1][3] ## Timeline and Delivery - **Processing**: Typically 2-3 weeks, but allow 4-6 weeks. They'll contact you or your doctor for verification.[1][9] - **Delivery**: Medication shipped free to your home or doctor's office. Track via phone.[1] - **Supply**: Initial 1-12 months; reauthorization needed annually or as supply ends.[1][6] ## Reauthorization and Refills **Reauthorization is required**. When supply is low (e.g., 12 months), your doctor resubmits or you request refill by calling 1-866-728-4368 or online portal. New proof may be needed.[1][6] ## Alternatives if Denied or Ineligible - **Copay Programs**: If insured, check GSKForYou copay assistance. - **Other Assistance**: NeedyMeds.org, RxAssist.org, or state programs. - **Generic Options**: No biosimilars for Incruse Ellipta; discuss alternatives like Spiriva with your doctor. - **Appeal**: Contact program for denial reasons and resubmit corrected docs.[2][6] ## Important Disclaimer This guide is for informational purposes based on publicly available program details as of 2026. Eligibility, terms, and availability can change—always verify with GSK at 1-866-728-4368 or gskforyou.com. Not medical advice; consult your healthcare provider. GSK makes no guarantees of approval. Do not rely solely on this; apply promptly.

Program information last verified: March 30, 2026